PYPD PolyPid Ltd.

NASDAQ
$4.74

PolyPid Ltd. (PYPD) is expected to report earnings on November 11, 2026, before the market open. The consensus earnings estimate is a loss of $0.41 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +3.3% since its last earnings release on August 12, 2026.

PolyPid Missed Consensus Estimates
Wednesday, August 12, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 7:30 AM ET
Earnings Whisper
-
vs ($0.41)
Rev est $30M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.81

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About PolyPid Ltd.

PolyPid Ltd. is a pharmaceutical company. It discovers, develops and commercializes antibiotic drugs for the prevention of surgical infections. The company's product candidate includes D-PLEX100, BONYPID-1000 and BONYPID-500 which are in clinical stage. PolyPid Ltd. is based in Petach Tikva, Israel.

Sector

Healthcare

Industry

Drug Manufacturers/Other